RAC Charts, page-130

First 130 Last

Share
Profile

Follow
EWexplorer

5,743 Posts.

1832

05/09/19

06:40

Post #: 40316532
Share

Originally posted by EWexplorer: ↑

Makes for interesting analysis ... was trying to figure out why the apportionment in the recent CR was as it was ... basically it appears to be a "catch up" for Dr Cullity given Dr Tillet was offered 8.5m ... DrT had started buying on market prior, around 5c, and had accumulated 200k before the CR.

DrC will likely be the conduit for discussion with pharmas in the US I expect - that's his background.

I don't want to make any outlandish statements here - so think about this strategically from an Exec perspective relative to share holder value and forthcoming responsibility.

Interesting.

It also suggests DrT was building a position and decided there might be a quicker way to achieve that.

That's the strategy ... but timing is also significant ... the 9.9c options seemed short termed from my perspective. Aug 2021 expiry.

In perspective - there are 49c, 65c, 30c and 45c opts expiring 2019/2020, and a heap of 25c ones expiring July 2021.

So to have 9.9's expiring Aug 2021 suggests they expect them to be in the money IMO ... as a standby for funds and/or reward for this CR.

If you consider who has the 25's expiring July 2021 and who benefits from these new 9.9's expiring Aug 2021 ... it's interesting to say the least.

Expand

The last weeks chart starting to "eyeball" as a triangle, target 15 or thereabouts. Makes sense at this stage.

RAC Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: Local bourse to trade green | Thursday September 12

CU6

Clarity progresses SECuRE trial with positive safety results

3 stocks with antimony news on Thursday

CHN

Chalice jumps on Putin nickel export ban threat – but then there's bad news

BRX

Belararox to grow copper footprint in Botswana with 4,286 square km tenure

SS1

Sun Silver confirms high-grade extension theory at Maverick Springs with 79.6 g/t intercept

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

MTM

Forget gallium: MTM says it's extracted gold from e-waste

NEC

Nine Entertainment announces its CEO is stepping down – on an ex-divvy day

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3